REFERENCES
1. Mehta, A.; Shapiro, M. D. Apolipoproteins in vascular biology and atherosclerotic disease. Nat. Rev. Cardiol. 2022, 19, 168-79.
2. 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet 2024, 403, 2162-203.
3. Kaufman, J. D.; Elkind, M. S. V.; Bhatnagar, A.; et al.; American Heart Association Advocacy Coordinating Committee. Guidance to reduce the cardiovascular burden of ambient air pollutants: a policy statement from the American heart association. Circulation 2020, 142, e432-47.
4. Niu, Y.; Zhou, Y.; Chen, R.; et al. Long-term exposure to ozone and cardiovascular = mortality in China: a nationwide cohort study. Lancet. Planet. Health. 2022, 6, e496-503.
5. Shearston, J. A.; Rowland, S. T.; Butt, T.; et al. Can traffic-related air pollution trigger myocardial infarction within a few hours of exposure? Environ. Int. 2023, 178, 108086.
6. Ma, Y.; Li, D.; Cui, F.; et al. Exposure to air pollutants and myocardial infarction incidence: a UK biobank study exploring gene-environment interaction. Environ. Health. Perspect. 2024, 132, 107002.
7. Kaufman, J. D.; Adar, S. D.; Barr, R. G.; et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the multi-ethnic study of atherosclerosis and air pollution): a longitudinal cohort study. Lancet 2016, 388, 696-704.
8. Yang, B. Y.; Guo, Y.; Markevych, I.; et al. Association of long-term exposure to ambient air pollutants with risk factors for cardiovascular disease in China. JAMA. Netw. Open. 2019, 2, e190318.
9. Anand, K.; Walia, G. K.; Mandal, S.; et al. Longitudinal associations between ambient PM2.5 exposure and lipid levels in two Indian cities. Environ. Epidemiol. 2024, 8, e295.
10. Guo, F.; Habre, R.; Xu, Y.; et al. Impact of childhood exposure to traffic related air pollution on adult cardiometabolic health: exploring the role of perceived stress. Environ. Res. 2024, 263, 120130.
11. Valdés, S.; Doulatram-Gamgaram, V.; Maldonado-Araque, C.; et al. Association between exposure to air pollution and blood lipids in the general population of Spain. Eur. J. Clin. Invest. 2024, 54, e14101.
12. Escher, B. I.; Stapleton, H. M.; Schymanski, E. L. Tracking complex mixtures of chemicals in our changing environment. Science 2020, 367, 388-92.
13. Gangwar, R. S.; Bevan, G. H.; Palanivel, R.; Das, L.; Rajagopalan, S. Oxidative stress pathways of air pollution mediated toxicity: recent insights. Redox. Biol. 2020, 34, 101545.
14. Waschek, J. A. VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Br. J. Pharmacol. 2013, 169, 512-23.
15. Haberzettl, P.; O‘Toole, T. E.; Bhatnagar, A.; Conklin, D. J. Exposure to fine particulate air pollution causes vascular insulin resistance by inducing pulmonary oxidative stress. Environ. Health. Perspect. 2016, 124, 1830-9.
16. Liu, C.; Chen, R.; Sera, F.; et al. Interactive effects of ambient fine particulate matter and ozone on daily mortality in 372 cities: two stage time series analysis. BMJ 2023, 383, e075203.
17. Palmisano, B. T.; Zhu, L.; Stafford, J. M. Role of estrogens in the regulation of liver lipid metabolism. Adv. Exp. Med. Biol. 2017, 1043, 227-56.
18. Knol, M. J.; VanderWeele, T. J.; Groenwold, R. H.; Klungel, O. H.; Rovers, M. M.; Grobbee, D. E. Estimating measures of interaction on an additive scale for preventive exposures. Eur. J. Epidemiol. 2011, 26, 433-8.
19. Yan, T.; Wang, W.; Xia, J.; et al. Exposure to the real ambient air pollutants alters the composition of nasal mucosa bacteria in the rat model. Chemosphere 2022, 287, 132269.
20. Borén, J.; Chapman, M. J.; Krauss, R. M.; et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart. J. 2020, 41, 2313-30.
21. Navarese, E. P.; Robinson, J. G.; Kowalewski, M.; et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA 2018, 319, 1566-79.
22. Chen, L.; Chen, S.; Bai, X.; et al. Low-density lipoprotein cholesterol, cardiovascular disease risk, and mortality in china. JAMA. Netw. Open. 2024, 7, e2422558.
23. Zhang, K.; Wang, H.; He, W.; et al. The association between ambient air pollution and blood lipids: a longitudinal study in Shijiazhuang, China. Sci. Total. Environ. 2021, 752, 141648.
24. Mao, S.; Chen, G.; Liu, F.; et al. Long-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population. Environ. Pollut. 2020, 256, 113403.
25. Wang, C.; Meng, X. C.; Huang, C.; et al. association between ambient air pollutants and lipid profile: a systematic review and meta-analysis. Ecotoxicol. Environ. Saf. 2023, 262, 115140.
26. Wang, L.; Chen, G.; Pan, Y.; et al.; China Multi-Ethnic Cohort (CMEC) collaborative group. Association of long-term exposure to ambient air pollutants with blood lipids in Chinese adults: the China multi-ethnic cohort study. Environ. Res. 2021, 197, 111174.
27. Miller, D. B.; Snow, S. J.; Henriquez, A.; et al. Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats. Toxicol. Appl. Pharmacol. 2016, 306, 47-57.
28. Wolf, K.; Hoffmann, B.; Andersen, Z. J.; et al. Long-term exposure to low-level ambient air pollution and incidence of stroke and coronary heart disease: a pooled analysis of six European cohorts within the ELAPSE project. Lancet. Planet. Health. 2021, 5, e620-32.
29. Zhang, Y.; Shi, J.; Ma, Y.; et al. Association between Air Pollution and Lipid Profiles. Toxics 2023, 11, 894.
30. Sepehri, B.; Darbani, R.; Mesgari-Abbasi, M.; et al. The effects of short-time air pollution, SO2, and ozone on biochemical, histo-pathological, oxidative stress, and carcinogenesis related genes expressions in the liver of the rats. Hum. Exp. Toxicol. 2024, 43, 9603271241263569.
31. Hu, R.; Zhang, L.; Qin, L.; et al. Airborne PM2.5 pollution: a double-edged sword modulating hepatic lipid metabolism in middle-aged male mice. Environ. Pollut. 2023, 324, 121347.
32. Zheng, Z.; Xu, X.; Zhang, X.; et al. Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J. Hepatol. 2013, 58, 148-54.
33. Xu, M. X.; Ge, C. X.; Qin, Y. T.; et al. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia. Free. Radic. Biol. Med. 2019, 130, 542-56.
34. Yin, F.; Gupta, R.; Vergnes, L.; et al. Diesel exhaust induces mitochondrial dysfunction, hyperlipidemia, and liver steatosis. Arterioscler. Thromb. Vasc. Biol. 2019, 39, 1776-86.
35. He, Z. Z.; Guo, P. Y.; Xu, S. L.; et al. Associations of particulate matter sizes and chemical constituents with blood lipids: a panel study in Guangzhou, China. Environ. Sci. Technol. 2021, 55, 5065-75.
36. Ge, C. X.; Qin, Y. T.; Lou, D. S.; et al. iRhom2 deficiency relieves TNF-α associated hepatic dyslipidemia in long-term PM2.5-exposed mice. Biochem. Biophys. Res. Commun. 2017, 493, 1402-9.
37. Zelcer, N.; Hong, C.; Boyadjian, R.; Tontonoz, P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325, 100-4.
38. de Sluis B, Wijers M, Herz J. News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1. Curr. Opin. Lipidol. 2017, 28, 241-7.
39. Sabatine, M. S. PCSK9 inhibitors: clinical evidence and implementation. Nat. Rev. Cardiol. 2019, 16, 155-65.
40. Lagace, T. A. PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells. Curr. Opin. Lipidol. 2014, 25, 387-93.
41. Sniderman, A. D.; Thanassoulis, G.; Glavinovic, T.; et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA. Cardiol. 2019, 4, 1287-95.
42. Chen, Z.; Newberry, E. P.; Norris, J. Y.; et al. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J. Lipid. Res. 2008, 49, 2013-22.
43. Magnusson, B.; Asp, L.; Boström, P.; et al. Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1566-71.
44. Tiwari, S.; Siddiqi, S.; Siddiqi, S. A. CideB protein is required for the biogenesis of very low density lipoprotein (VLDL) transport vesicle. J. Biol. Chem. 2013, 288, 5157-65.
45. Chen, Z.; Norris, J. Y.; Finck, B. N. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB). J. Biol. Chem. 2010, 285, 25996-6004.
46. Pan, X.; Zhang, Y.; Wang, L.; Hussain, M. M. Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. Cell. Metab. 2010, 12, 174-86.
47. Qiu, W.; Avramoglu, R. K.; Rutledge, A. C.; Tsai, J.; Adeli, K. Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins. J. Lipid. Res. 2006, 47, 1749-61.
48. Wang, S.; Chen, Z.; Lam, V.; et al. IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis. Cell. Metab. 2012, 16, 473-86.
49. Zhang, K.; Tian, L.; Sun, Q.; et al. Constructing an adverse outcome pathway framework for the impact of maternal exposure to PM2.5 on liver development and injury in offspring. Environ. Toxicol. Pharmacol. 2024, 112, 104585.
50. Stachyra, K.; Kiepura, A.; Suski, M.; et al. Changes in the liver proteome in apoE knockout mice exposed to inhalation of silica nanoparticles indicate mitochondrial damage and impairment of ER stress responses associated with microvesicular steatosis. Environ. Sci. Pollut. Res. Int. 2023, 30, 699-709.
51. Ibrahim, I. M.; Abdelmalek, D. H.; Elfiky, A. A. GRP78: A cell's response to stress. Life. Sci. 2019, 226, 156-63.
52. Qiu, W.; Su, Q.; Rutledge, A. C.; Zhang, J.; Adeli, K. Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling. J. Lipid. Res. 2009, 50, 1814-23.
